Organization: Health Canada
Year: 2023
Month: October
Request Number: A-2023-000303
Request Summary: Provide the disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) inspection of the Merck Canada facility in Kirkland, Quebec, starting around 7 November 2022. Reference Number 502785.
Disposition: Disclosed in part
Number of pages: 21